Opens in a new tab

Roadmap

The next level of responsible development.

Rigorous science, built on partnership with the people who carried this knowledge, respect for the ecosystems and medicine traditions it comes from, and access for as many people as possible.

The path

01

Proof of concept

Fall 2026 – 2027

Proof-of-concept testing building on our exploratory studies, with HPLC standardisation of plant material. Grant applications underway.

02

Relationships in Indonesia

2026 – 2027

Travel to Indonesia to meet the researchers who carried this work before us, and to begin partnership conversations with Nimboran communities. Separate travel-grant application underway.

03

Safety

Following proof of concept

Preliminary safety work, drawing on existing Indonesian research and traditional-medicine data alongside our own studies.

04

Natural health product / supplement

When the safety profile supports it

A natural health product (Canada) / dietary supplement (US), once early safety data is in, bringing the plant to people and generating revenue while the clinical pathway continues.

05

Clinical validation

Multi-year

Clinical trials and regulatory engagement toward a validated contraceptive claim.

Our commitments

How we build.

Every stage of the roadmap is shaped by four commitments.

Access for as many people as possible

Including the world's poor. We're building toward a business model that makes this medicine reachable in every market, not only the wealthiest ones.

Partnership with the Nimboran and Indonesia

This knowledge comes from the Nimboran people and decades of Indonesian research. We're building relationships with both, with benefit-sharing built into the company.

Respect for ecosystems

Sourcing and cultivation that sustain the places this plant grows, and the communities who depend on them.

Respect for ethnomedicine

Traditional medicine systems are knowledge in their own right. We learn from them, credit them, and support their preservation.